Trials / Completed
CompletedNCT01037426
Falls and Cardiovascular Events in Pacemaker Patients
Falls and Cardiovascular Events in Elderly Patients With Sinus Node Disease Treated With a MVPTM Pacemaker According to the ESC 2007 Guidelines
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 87 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to document the number of falls and fractures in Sinus Node Disease (SND) patients.
Detailed description
The purpose of this study is to compare the number of falls and fractures in Sinus Node Disease (SND) patients before versus after implantation of a MVP (TradeMark) pacemaker. Further the effect of pacing in the MVP (TradeMark) mode in respect of cardiovascular events is going to be analyzed in the same population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fill out Questionnaire | Questionnaire at time of Implantation and 12 months after pacemaker implantation to collect * History of falls and fractures during the 12 months before pacemaker implantation * Risk markers for falls based on FRAX risk calculator (age, gender, weight, height, history of previous fracture, family history of hip fracture, current smoking habits, glucocorticosteroid intake, rheumatoid arthritis, secondary osteoporosis, alcohol intake) * History of falls and fractures during the 12 months after pacemaker implantation * Medical and Arrhythmia History * Cardiovascular Events * Cardiovascular Medication * Device programming information |
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2009-12-23
- Last updated
- 2025-07-03
Locations
8 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT01037426. Inclusion in this directory is not an endorsement.